ACTRN12609000308291已完成未知
Investigation into the effect of a nutritional supplement on attention and mood in a clinical sample of adults with Attention-Deficit/Hyperactivity Disorder (ADHD): a double blind randomized placebo controlled trial with open label extension.
Julia Rucklidge0 个研究点目标入组 80 人开始时间: 2009年5月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 16 Years 至 75 Years（—）
- 性别
- All
入选标准
- •1.Participants are older than 16 years of age. 2.Each participant must have a level of understanding sufficient to complete the questionnaires and examinations required by the protocol and be considered reliable and compliant with the protocol (including the ingestion of as many as 15 capsules/day). 3.Participants must be able to eat at least a snack three times per day, so that the capsules will not be ingested on an empty stomach. 4.Participants meet criteria for ADHD.
排除标准
- •1) neurological disorder involving brain or other central function (e.g., epilepsy, multiple sclerosis (MS), narcolepsy), 2) any serious medical condition for which major medical interventions was anticipated during the trial, 3) any patient known to be allergic to the ingredients of the intervention, 4) pregnancy or breastfeeding (pregnancy testing occurred at baseline and monthly thereafter), 5) evidence of untreated or unstable thyroid disease (thyroid testing will occur at baseline), 6) any known abnormality of mineral metabolism (e.g., Wilson’s disease, haemochromatosis), 7) evidence of substance dependence within the previous month, 8) any other medication with primarily central nervous system activity, including mood stabilizers (participants must have been off of these medications for a minimum of 4 weeks prior to the trial), 9) patients were excluded temporarily if they had taken an oral antibiotic in the previous 6 weeks (if an antibiotic was started during the course of the trial, that patient was withdrawn from the study), 10) any type of nutritional or herbal supplement, known to have a centrally-acting effect (patients who had been taking supplements such as echinacea, chondroitin, or glucosamine could enter the study if a) they have been taking these agents for at least one month prior to the study, and b) they continued on these agents throughout the study), and 11) any subject judged clinically to be at serious risk for suicide or violence in the opinion of the researchers.
研究者
相似试验
已完成
不适用
utritional supplements and withdrawal symptoms in smoking cessation.ACTRN12613001188729niversity of Canterbury24
已完成
不适用
A randomized controlled trial investigating the efficacy and safety of a micronutrient formula in the treatment of Attention-Deficit/Hyperactivity Disorder in childreADHDAlternative and Complementary Medicine - Other alternative and complementary medicineMental Health - Other mental health disordersACTRN12613000896774niversity of Canterbury93
已完成
1 期
Effect of a nutritional supplement on attention and mood in adults with Attention-Deficit/Hyperactivity DisorderAttention-Deficit/Hyperactivity DisorderMood instabilityMental Health - Other mental health disordersMental Health - DepressionACTRN12609000202268Julia Rucklidge15
已完成
不适用
A natural approach to treating premenstrual complaints: a randomized control trial comparing Vitamin B6 to a Broad Spectrum Micronutrient formula.Premenstrual syndrome (PMS)Women's mental healthMental Health - Other mental health disordersReproductive Health and Childbirth - Menstruation and menopauseACTRN12615000131550niversity of Canterbury80
尚未招募
2 期
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase IIColorectal NeoplasmsMetastatic colorectal adenocarcinomaIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsRectal DiseasesColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesRPCEC00000276Catalysis S40